Chlamydial Disease: A Crossroad Between Chronic Infection and Development of Cancer
Authors:
Carlo Contini
Bron: Researchgate.net, lees meer
Chlamydial Disease: A Crossroad Between Chronic Infection and Development of Cancer
@VerlorengezondheidM, wees alert en leer je beter in te lezen: er is voor hetgeen A.S stelt in de jarenlange presentaties géén medisch én wetenschappelijk bewijs!; Bron viewtopic.php?f=5&t=2595&start=90#p28916 en Bron (Part 1 & Part 2); viewtopic.php?f=5&t=2595&start=190#p29473VerlorengezondheidM schreef:Dr.-Schwarzbach-Pathogens-and-cancer-London-March-24-2018-1.pdf; Bron https://aonm.b-cdn.net/wp-content/uploa ... 4-2018.pdf en Bron; https://aonm.org/aonm-conference-how-pr ... r-therapy/
Appraisal of the causal effect of Chlamydia trachomatis infection on epithelial ovarian cancer risk: a two-sample Mendelian randomisation study
New hypothesis proposed for how chlamydia might increase cancer and ectopic pregnancy risk
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer
Chronic Infections With Lyme And Other Tickborne Pathogens
Gastrointestinal Coinfection Promotes Chlamydial Pathogenicity in the Genital Tract
Chlamydia trachomatis: From Urogenital Infections to the Pathway of Infertility
1) [9]. After completing these replication cycles, RBs re-differentiate back into EBs, which then can be released through host cell lysis or through extrusion to infect other cells, continuing the infection process [11]. Importantly, the RBs can enter a persistent non-replicative state under adverse conditions and cellular stress, dedifferentiated into aberrant bodies (ABs), leading to a chronic infection that is difficult to diagnose and treat [12]. In this state of persistence, the pathogen evades immune detection because it is less metabolically active and less susceptible to antibiotics [13].
Gebruikers op dit forum: Geen geregistreerde gebruikers en 2 gasten